TNM002
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TNM002, covering 2024-09-23 to 2025-09-16. Get the full timeline:
Most recent: Clinical Trial Update: Study to Compare the Anti-tetanus Neutralizing Antibody Titers and Safety of TNM002 Injection With Human Tetanus Immunoglobulin or Placebo in Adult Volunteers [Phase 2]